Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

5-CTG CCA CGT TCT CCT GC-(2 methoxy)A-(2 methoxy)C-(2 methoxy)C-3

EU orphan designation number: EU/3/04/203   
Active ingredient: 5’-CTG CCA CGT TCT CCT GC-(2’ methoxy)A-(2’ methoxy)C-(2’ methoxy)C-3’
Indication: Treatment of myasthenia gravis
Sponsor: PPD Global Ltd
Granta Park, Great Abington, Cambridge, Cambridgeshire CB21 6GQ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/06/2004 Orphan Designation EMEA/OD/008/04 (2004)2310 of 21/06/2004